Cwm LLC Decreases Stock Position in Lam Research Co. (NASDAQ:LRCX)

Cwm LLC trimmed its holdings in shares of Lam Research Co. (NASDAQ:LRCXFree Report) by 4.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,027 shares of the semiconductor company’s stock after selling 185 shares during the quarter. Cwm LLC’s holdings in Lam Research were worth $3,154,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Orion Capital Management LLC purchased a new stake in shares of Lam Research during the 3rd quarter valued at about $25,000. BluePath Capital Management LLC purchased a new stake in shares of Lam Research during the 3rd quarter valued at about $28,000. OFI Invest Asset Management purchased a new stake in shares of Lam Research during the 3rd quarter valued at about $30,000. Asset Dedication LLC raised its position in shares of Lam Research by 56.7% during the 3rd quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock valued at $30,000 after buying an additional 17 shares in the last quarter. Finally, Valued Wealth Advisors LLC purchased a new stake in shares of Lam Research during the 4th quarter valued at about $30,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Price Performance

NASDAQ LRCX opened at $884.89 on Thursday. Lam Research Co. has a 52-week low of $493.42 and a 52-week high of $1,007.39. The firm’s 50 day moving average price is $943.93 and its 200-day moving average price is $806.38. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.02 and a current ratio of 3.06. The company has a market cap of $116.01 billion, a PE ratio of 34.22, a P/E/G ratio of 3.21 and a beta of 1.51.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 EPS for the quarter, beating analysts’ consensus estimates of $7.06 by $0.46. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The company had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the prior year, the company posted $10.71 earnings per share. Lam Research’s revenue for the quarter was down 28.8% compared to the same quarter last year. Sell-side analysts forecast that Lam Research Co. will post 28.96 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 3rd. Shareholders of record on Wednesday, March 13th were issued a $2.00 dividend. The ex-dividend date of this dividend was Tuesday, March 12th. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.90%. Lam Research’s dividend payout ratio is currently 30.94%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on LRCX. Citigroup upped their target price on shares of Lam Research from $800.00 to $975.00 and gave the company a “buy” rating in a research report on Thursday, January 25th. B. Riley upgraded shares of Lam Research from a “neutral” rating to a “buy” rating and upped their price target for the company from $870.00 to $1,100.00 in a report on Friday, April 19th. Deutsche Bank Aktiengesellschaft started coverage on shares of Lam Research in a report on Thursday, April 11th. They set a “hold” rating and a $1,000.00 price target on the stock. Needham & Company LLC upped their price target on shares of Lam Research from $900.00 to $1,030.00 and gave the company a “buy” rating in a report on Thursday, April 18th. Finally, Raymond James upped their price target on shares of Lam Research from $850.00 to $950.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. Seven equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $931.85.

Check Out Our Latest Research Report on LRCX

Insiders Place Their Bets

In related news, Director Abhijit Y. Talwalkar sold 882 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the transaction, the director now owns 10,541 shares of the company’s stock, valued at $10,246,168.23. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director Abhijit Y. Talwalkar sold 882 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the sale, the director now owns 10,541 shares in the company, valued at $10,246,168.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the firm’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now owns 22,095 shares in the company, valued at approximately $20,380,648.95. The disclosure for this sale can be found here. Over the last quarter, insiders sold 7,029 shares of company stock valued at $6,559,489. Insiders own 0.32% of the company’s stock.

Lam Research Company Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Recommended Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.